Thursday, October 15, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· January 8, 2026

Minim Martap Development Update

View original at globenewswire.com
Minim Martap Development Update Highlights The surface miner has arrived in Cameroon, with mining operations scheduled to commence in February 2026.Delivery of locomotives and wagons scheduled in Q1, 2026…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The alumina refinery Feasibility Study is progressing well and is 45% complete

    80% confidence

  • EEA reaffirms commitment to completing the A$100 million Tranche 2 equity funding subject to shareholder approval anticipated in early March 2026

    80% confidence

  • Ore haulage from the Inland Rail Facility to the Port of Douala is planned for Q2, 2026

    80% confidence

  • Discussions with Camrail regarding the increase in ownership from 9% to approximately 35% are ongoing and expected to be completed in Q1, 2026

    80% confidence

  • First bauxite shipment targeted for late June 2026

    80% confidence

  • Canyon is fully funded through Stage 1 production through a balanced mix of debt and equity

    80% confidence

  • Discussions with Camrail regarding an increased equity interest are nearing completion and expected to support greater involvement in critical rail infrastructure upgrades

    80% confidence

  • Delivery of locomotives and wagons scheduled in Q1, 2026

    80% confidence

  • The alumina refinery Feasibility Study is advancing well and reinforcing Canyon's long-term, value-add development strategy

    80% confidence

  • Key operational milestones continue to be achieved across mining, logistics and infrastructure workstreams

    80% confidence

  • Afriland remains fully supportive of Canyon and the advancement of the Minim Martap Bauxite Project

    80% confidence

  • The surface miner has arrived in Cameroon, with mining operations scheduled to commence in February 2026

    80% confidence

  • Canyon continues to make strong progress across key project milestones

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com